基于文献数据库的中国高校“药理学与毒理学”学科进展及研究热点分析
Analysis of the progress and research hotspots of “Pharmacology and Toxicology” in Chinese universities based on the databases
-
摘要: 综合使用ESI，JCR，InCites，WoS数据库，检索“药理学与毒理学”学科文献数据，利用文献计量学、统计学等多种分析方法，分析该学科中国高校的发展现状。以进入ESI排名前100名的中国高校为例，详细分析了该学科多指标状况，重点分析了目前该学科中国高校高被引论文的发文类别、引用情况、发文期刊、发文机构及团队、研究前沿热点等内容。通过总结“药理学与毒理学”学科中国高校研究现状和聚焦领域，以期为各个高校该学科的建设和发展提供数据及决策参考。Abstract: This paper using ESI,JCR,InCites,and WoS database,the data of Pharmacology and Toxicology were retrieved,and the development status of domestic universities was analyzed by using bibliometrics,statistics and other analysis methods. Taking Chinese universities ranked in the top 100 of ESI as an example,the multi-index status of the subject was analyzed in detail,and the publication category,citation of the highly cited papers in domestic universities were analyzed emphatically on journals,publishing institutions and teams,research frontiers and hot spots,etc. In order to provide data and decision-making references for the construction and development of Pharmacology and Toxicology,the domestic research status and frontier hot spots of Pharmacology and Toxicology were summarized.
-
-
[1] .（ 2017-01-25 ）［2020-08-15 ］.http：//edu.people.com.cn/n1/2017/0125/c1006-29049551.html .[2] Hu JH. The influence of “Double First-class” construction on the discipline development in China''''s universities［J］. Jiangsu Higher Educ（江苏高教），2018（7）：5?8，13. [3] Zhang JL，Chen TZ. On the discipline development planning in the construction of “Double First-Class”：strategy，management，and effectiveness—case studies of two institutions building into world-class universities［J］. China Higher Educ Res（中国高教研究），2018（7）：22?29. [4] Liu BH，Zhang HR，Wang HW. The contrastive analysis of mathematical subject data based on ESI and thoughts on discipline construction—taking the mathematics of Wuhan University as an example［J］. Document Inform Knowl（图书情报知识），2017（1）：114?122. [5] Song LP，Wang JF. An empirical study of scientific evaluation based on the correlation between CNCI and peer review［J］. Lib Inform Ser（图书情报工作），2018，62（18）：122?128. [6] Yang FJ，Liang Z，Xue L，et al. Assessing the effects of the Chinese state key laboratory initiative［J］. Sci Sci Managem S& T（科学学与科学技术管理），2019，40（2）：26?39. [7] Ding S. Analysis on the influencing factors of scientific research development in affiliated hospitals of colleges and universities and countermeasures［C］. Proceedings of the Third National Forum on Medical Research Management and Annual Meeting of Jiangsu Province. Nanjing ，China ，2011.[8] Shen TP，Yang ST，Chu JW. Hotspot of knowledge chain research based on the co-words analysis［J］. New Cent Lib（新世纪图书馆），2014（1）：88?92. [9] Mao SR，Sun W，Kissel T. Chitosan-based formulations for delivery of DNA and siRNA［J］. Adv Drug Deliv Rev，2010，62（1）：12?27. [10] Banerjee A，Qi JP，Gogoi R，et al. Role of nanoparticle size，shape and surface chemistry in oral drug delivery［J］. J Control Release，2016，238：176?185. [11] Zhang SY，Liu YJ，Gan Y，et al. Conjugates of TAT and folate with DOX-loaded chitosan micelles offer effective intracellular delivery ability［J］. Pharm Dev Technol，2019，24（2）：253?261. [12] Wei X，Yang X，Han ZP，et al. Mesenchymal stem cells：a new trend for cell therapy［J］. Acta Pharm Sin（药学学报），2013，34（6）：747?754. [13] Chen XM，Song EW. Turning foes to friends：targeting cancer-associated fibroblasts［J］. Nat Rev Drug Discov，2019，18（2）：99?115. [14] Guo ZR. The modification of natural products for medical use［J］. Acta Pharma Sin B，2017，7（2）：119?136. [15] Williamson EM，Liu XM，Izzo AA. Trends in use，pharmacology，and clinical applications of emerging herbal nutraceuticals［J］. Brit J Pharmacol，2020，177（6）：1227?1240. [16] Zhang Y，Huo MR，Zhou JP. et al. DDSolver：an add-in program for modeling and comparison of drug dissolution profiles［J］. The AAPS J，2010，12（3）：263?271. -
期刊类型引用(1)
1. 王田静，谭奇纹，李林蔚，于子如，于慧娟. 基于内质网应激途径探讨中医药防治非酒精性脂肪性肝病. 中西医结合肝病杂志. 2024(07): 665-669 . 
百度学术
其他类型引用(3)
计量
- 文章访问数: 254
- HTML全文浏览量: 9
- PDF下载量: 819
- 被引次数: 4
下载:
